Skip to content

Clinical trials

Hypercholesterolemia trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Not applicable Country / region: United States Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20024
20031
20042
20051
20064
20078
20087
20094
20101
20112
20127
20137
20143
20152
20166
20174
20185
20192
20204
20213
20233
20245
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Recruiting9
Terminated4
Unknown status4
Withdrawn3
Enrolling by invitation3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine5
Duke University3
Northwestern University3
The Cleveland Clinic3
Brigham and Women's Hospital2
Durham VA Medical Center2
Massachusetts General Hospital2
National Institute of Allergy and Infectious Diseases (NIAID)2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Ohio State University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia100
Hypertension34
Diabetes Mellitus32
Obesity23
Cardiovascular Diseases13
Hyperlipidemias11
Diabetes Mellitus, Type 29
Overweight9
Hyperglycemia6
Metabolic Syndrome6

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.